top of page

Merck’s anti-viral pill for COVID-19 treatment could come in a matter of weeks

Drug maker Merck has asked U.S. regulators in the Food and Drug Administration last Monday to authorize its new antiviral pill for treatment of COVID-19 in what would add an entirely new and easy-to-use tool to battle the pandemic.

Want to read more?

Subscribe to to keep reading this exclusive post.



Não foi possível carregar comentários
Parece que houve um problema técnico. Tente reconectar ou atualizar a página.
bottom of page